CardioDx Overview

  • Founded
  • 2004
Founded
  • Status
  • Out of Business
  • Employees
  • 156
Employees
  • Latest Deal Type
  • Out of Business

CardioDx General Information

Description

CardioDx Inc was incorporated in Delaware in July 2003. The Company is a molecular diagnostics company developing and commercializing novel, proprietary tests that help improve treatment decisions, enhance patient outcomes and reduce the overall cost of care. It uses genomic technologies to provide healthcare professionals with critical, actionable information to improve patient care and management. It focuses on diagnostics for cardiovascular diseases, such as coronary artery diseases, or CAD, arrhythmia and heart failure. Its Corus CAD test is a blood-based gene expression test that provides a current-state assessment for non-diabetic patients with symptoms that aremore

Contact Information

Website
www.cardiodx.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Decision/Risk Analysis
Biotechnology
Primary Office
  • 600 Saginaw Drive
  • Redwood City, CA 94063
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CardioDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Out of Business 09-Jan-2019 00000 Completed Out of Business
13. Later Stage VC (Series 1) 17-Jan-2017 000.00 00000 000.00 Completed Generating Revenue
12. Later Stage VC (Series DD) 22-Feb-2016 000.00 00000 00000 Completed Generating Revenue
11. Debt - General 01-Sep-2015 0000 00000 Completed Generating Revenue
10. Mezzanine 08-Jun-2015 00.000 00000 Completed Generating Revenue
9. IPO 23-Dec-2014 0000 Cancelled Generating Revenue
8. Later Stage VC (Series DD) 18-Dec-2014 0000 00000 00000 Completed Generating Revenue
7. Later Stage VC (Series DD) 23-Jul-2014 0000 00000 00000 Completed Generating Revenue
6. Later Stage VC (Series CC) 27-Aug-2012 $88M $228M 00000 Completed Generating Revenue
5. Later Stage VC (Series BB) 11-May-2011 $60M $140M 00000 Completed Generating Revenue
To view CardioDx’s complete valuation and funding history, request access »

CardioDx Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series 1B 00,000,000 00.000000 00.0 00.00 00.0 00 00.00 000
Series 1A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view CardioDx’s complete cap table history, request access »

CardioDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
CardioDx Inc was incorporated in Delaware in July 2003. The Company is a molecular diagnostics company developing and co
Laboratory Services (Healthcare)
Redwood City, CA
156 As of 2015
00000
00000000 00 00000

00000 00

oris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate ve
0000000000000
Aliso Viejo, CA
000 As of 0000
00 0000-00-00
000000&0

000000

, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut
0000000000000
Minneapolis, MN
00 As of 0000
00.000
0000000000 0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CardioDx Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ambry Genetics Private Equity-Backed Aliso Viejo, CA 000 000000&0
000000 Venture Capital-Backed Minneapolis, MN 00 00.000 0000000000 0 00.000
000000 000000 Venture Capital-Backed South Plainfield, NJ 00 000000000 -
000000000000 Venture Capital-Backed Singapore, Singapore 00 00.000 00000 00000 00.000
000000000 00000000 Formerly VC-backed Cleveland, OH 00 000.00 000000&0 000.00
You’re viewing 5 of 18 competitors. Get the full list »

CardioDx Patents

  • 33

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

CardioDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2996191-A1 Markers for coronary artery disease and uses thereof Abandoned 01-Sep-2015 00000000000
EP-3344986-A4 Markers for coronary artery disease and uses thereof Withdrawn 01-Sep-2015 00000000000 0
EP-3344986-A1 Markers for coronary artery disease and uses thereof Withdrawn 01-Sep-2015 00000000000
US-20180356432-A1 Markers for coronary artery disease and uses thereof Abandoned 01-Sep-2015 00000000000
AU-2012300375-A1 Methods and compositions for determining smoking status Abandoned 29-Aug-2011 G16H50/30
To view CardioDx’s complete patent history, request access »

CardioDx Executive Team (21)

Name Title Board Seat Contact Info
David Levison Founder, Chief Strategy Officer & Board Member
Robert Werner Senior Director, Finance & Corporate Controller
James Wingrove Vice President, Technical Operations and Head of Research
You’re viewing 3 of 21 executive team members. Get the full list »

CardioDx Board Members (15)

Name Representing Role Since
Andrew Guggenhime Self Board Member 000 0000
David Levison CardioDx Founder, Chief Strategy Officer & Board Member 000 0000
James Tobin Self Board Member 000 0000
You’re viewing 3 of 15 board members. Get the full list »

CardioDx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial